| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 29 | 2024 | 477 | 6.890 |
Why?
|
| RNA-Binding Protein FUS | 14 | 2023 | 50 | 5.750 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2024 | 137 | 1.710 |
Why?
|
| Mutation | 19 | 2024 | 2466 | 1.690 |
Why?
|
| Nuclear Pore Complex Proteins | 2 | 2023 | 26 | 1.560 |
Why?
|
| Neurodegenerative Diseases | 4 | 2024 | 128 | 1.550 |
Why?
|
| Profilins | 4 | 2024 | 45 | 1.530 |
Why?
|
| Frontotemporal Dementia | 6 | 2023 | 126 | 1.490 |
Why?
|
| Superoxide Dismutase | 7 | 2022 | 214 | 1.480 |
Why?
|
| Motor Neurons | 7 | 2022 | 206 | 1.380 |
Why?
|
| Stress, Physiological | 3 | 2019 | 186 | 1.340 |
Why?
|
| Brain Injuries, Traumatic | 4 | 2023 | 80 | 1.290 |
Why?
|
| Cytoplasmic Granules | 4 | 2019 | 50 | 1.150 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2023 | 106 | 1.080 |
Why?
|
| Neurons | 10 | 2023 | 861 | 1.030 |
Why?
|
| Superoxide Dismutase-1 | 9 | 2022 | 136 | 0.980 |
Why?
|
| Microglia | 3 | 2024 | 229 | 0.920 |
Why?
|
| Skull | 1 | 2023 | 57 | 0.840 |
Why?
|
| Single-Domain Antibodies | 1 | 2022 | 16 | 0.820 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2023 | 83 | 0.810 |
Why?
|
| Protein Folding | 9 | 2022 | 261 | 0.800 |
Why?
|
| Polymerization | 1 | 2021 | 35 | 0.740 |
Why?
|
| Axonal Transport | 3 | 2017 | 31 | 0.740 |
Why?
|
| Actins | 2 | 2021 | 258 | 0.680 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 667 | 0.660 |
Why?
|
| Golgi Apparatus | 1 | 2019 | 64 | 0.640 |
Why?
|
| Receptors, AMPA | 1 | 2019 | 42 | 0.640 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2017 | 125 | 0.640 |
Why?
|
| Animals | 26 | 2023 | 19739 | 0.630 |
Why?
|
| Glutamic Acid | 1 | 2019 | 99 | 0.620 |
Why?
|
| Cell Nucleus | 4 | 2019 | 605 | 0.610 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 167 | 0.590 |
Why?
|
| Mice | 19 | 2023 | 10317 | 0.570 |
Why?
|
| Humans | 41 | 2024 | 60081 | 0.560 |
Why?
|
| Protein Biosynthesis | 1 | 2019 | 296 | 0.550 |
Why?
|
| Proteostasis Deficiencies | 2 | 2021 | 6 | 0.550 |
Why?
|
| Cyclophilin A | 2 | 2010 | 35 | 0.540 |
Why?
|
| Oxidative Stress | 4 | 2013 | 282 | 0.530 |
Why?
|
| Calcium | 2 | 2019 | 559 | 0.510 |
Why?
|
| Cells | 1 | 2014 | 31 | 0.460 |
Why?
|
| Cytoplasm | 5 | 2023 | 274 | 0.450 |
Why?
|
| RNA, Messenger | 2 | 2019 | 1465 | 0.450 |
Why?
|
| Hypertonic Solutions | 1 | 2013 | 5 | 0.450 |
Why?
|
| Epitopes | 1 | 2014 | 294 | 0.420 |
Why?
|
| DNA Repair | 1 | 2014 | 236 | 0.400 |
Why?
|
| Cell Line | 6 | 2018 | 2008 | 0.390 |
Why?
|
| Mutant Proteins | 4 | 2021 | 105 | 0.380 |
Why?
|
| HIV-1 | 2 | 2010 | 710 | 0.370 |
Why?
|
| Autoantibodies | 1 | 2011 | 175 | 0.360 |
Why?
|
| Brain | 7 | 2023 | 1485 | 0.350 |
Why?
|
| Cell Proliferation | 1 | 2014 | 944 | 0.350 |
Why?
|
| Capsid Proteins | 1 | 2010 | 93 | 0.330 |
Why?
|
| Spinal Cord | 5 | 2018 | 199 | 0.310 |
Why?
|
| Protein Conformation | 5 | 2015 | 774 | 0.300 |
Why?
|
| C9orf72 Protein | 3 | 2023 | 98 | 0.280 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 311 | 0.280 |
Why?
|
| alpha-Synuclein | 2 | 2006 | 20 | 0.270 |
Why?
|
| Oxidation-Reduction | 5 | 2018 | 305 | 0.270 |
Why?
|
| HeLa Cells | 2 | 2021 | 530 | 0.270 |
Why?
|
| Lewy Body Disease | 1 | 2006 | 7 | 0.260 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2019 | 87 | 0.260 |
Why?
|
| Cholesterol | 2 | 2006 | 255 | 0.250 |
Why?
|
| Proteomics | 2 | 2019 | 264 | 0.240 |
Why?
|
| Crystallography, X-Ray | 3 | 2015 | 424 | 0.240 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 2074 | 0.220 |
Why?
|
| Pick Disease of the Brain | 1 | 2023 | 5 | 0.220 |
Why?
|
| Models, Molecular | 6 | 2012 | 1139 | 0.210 |
Why?
|
| Intravital Microscopy | 1 | 2023 | 12 | 0.210 |
Why?
|
| Brain Concussion | 1 | 2023 | 28 | 0.210 |
Why?
|
| Proteins | 3 | 2015 | 738 | 0.210 |
Why?
|
| Cysteine | 2 | 2014 | 109 | 0.210 |
Why?
|
| Neuronal Outgrowth | 1 | 2022 | 10 | 0.210 |
Why?
|
| Coloring Agents | 1 | 2023 | 54 | 0.210 |
Why?
|
| Mass Spectrometry | 3 | 2014 | 288 | 0.210 |
Why?
|
| Cytophagocytosis | 1 | 2022 | 2 | 0.210 |
Why?
|
| Head | 1 | 2023 | 52 | 0.200 |
Why?
|
| Synaptosomes | 1 | 2022 | 16 | 0.200 |
Why?
|
| Chronic Traumatic Encephalopathy | 1 | 2021 | 5 | 0.190 |
Why?
|
| Recombinant Proteins | 3 | 2014 | 694 | 0.190 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2021 | 21 | 0.190 |
Why?
|
| Tauopathies | 1 | 2021 | 15 | 0.190 |
Why?
|
| Capsid | 1 | 2002 | 89 | 0.190 |
Why?
|
| Phagocytosis | 1 | 2022 | 252 | 0.180 |
Why?
|
| DNA Repeat Expansion | 2 | 2023 | 53 | 0.180 |
Why?
|
| Superoxides | 1 | 2020 | 69 | 0.180 |
Why?
|
| Animals, Genetically Modified | 1 | 2021 | 281 | 0.170 |
Why?
|
| Cell Differentiation | 2 | 2022 | 1298 | 0.170 |
Why?
|
| Decapodiformes | 2 | 2017 | 14 | 0.170 |
Why?
|
| Coat Protein Complex I | 1 | 2019 | 5 | 0.170 |
Why?
|
| Arsenites | 1 | 2019 | 7 | 0.170 |
Why?
|
| Weight Loss | 1 | 2021 | 264 | 0.160 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2018 | 21 | 0.160 |
Why?
|
| Mutation, Missense | 2 | 2010 | 178 | 0.150 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2010 | 111 | 0.150 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 38 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 324 | 0.150 |
Why?
|
| Drosophila | 1 | 2021 | 420 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 677 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 666 | 0.150 |
Why?
|
| Phenotype | 1 | 2021 | 1145 | 0.140 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 1387 | 0.140 |
Why?
|
| Male | 10 | 2023 | 27951 | 0.130 |
Why?
|
| Protein Binding | 3 | 2014 | 1571 | 0.130 |
Why?
|
| Isoenzymes | 2 | 2014 | 130 | 0.130 |
Why?
|
| Kinetics | 3 | 2010 | 737 | 0.130 |
Why?
|
| Astrocytes | 3 | 2022 | 116 | 0.130 |
Why?
|
| Dipeptides | 1 | 2015 | 61 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 201 | 0.120 |
Why?
|
| Phosphorylation | 2 | 2014 | 860 | 0.120 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2014 | 257 | 0.120 |
Why?
|
| M Phase Cell Cycle Checkpoints | 1 | 2014 | 5 | 0.120 |
Why?
|
| Hybridomas | 1 | 2014 | 65 | 0.120 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 75 | 0.120 |
Why?
|
| Gene Expression | 2 | 2014 | 808 | 0.120 |
Why?
|
| Genetic Association Studies | 2 | 2014 | 117 | 0.110 |
Why?
|
| Escherichia coli | 2 | 2014 | 688 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 193 | 0.110 |
Why?
|
| In Vitro Techniques | 2 | 2015 | 471 | 0.110 |
Why?
|
| Sorbitol | 1 | 2013 | 2 | 0.110 |
Why?
|
| Protein Structure, Secondary | 1 | 2014 | 255 | 0.110 |
Why?
|
| Methylation | 1 | 2013 | 127 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2011 | 356 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 217 | 0.110 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 69 | 0.100 |
Why?
|
| Cell Death | 1 | 2013 | 272 | 0.100 |
Why?
|
| Autophagy | 1 | 2014 | 209 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2013 | 592 | 0.100 |
Why?
|
| Survival | 1 | 2011 | 12 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 1224 | 0.100 |
Why?
|
| Transduction, Genetic | 1 | 2013 | 233 | 0.100 |
Why?
|
| Cell Survival | 1 | 2013 | 558 | 0.100 |
Why?
|
| Adult | 4 | 2018 | 15972 | 0.100 |
Why?
|
| Middle Aged | 4 | 2018 | 16542 | 0.090 |
Why?
|
| Histones | 1 | 2014 | 465 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2013 | 585 | 0.090 |
Why?
|
| RNA Interference | 1 | 2014 | 592 | 0.090 |
Why?
|
| Female | 7 | 2023 | 31226 | 0.090 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2010 | 34 | 0.090 |
Why?
|
| Amino Acid Sequence | 5 | 2013 | 1572 | 0.090 |
Why?
|
| Epitope Mapping | 1 | 2010 | 47 | 0.090 |
Why?
|
| Models, Biological | 3 | 2010 | 1142 | 0.090 |
Why?
|
| Esterases | 1 | 2010 | 13 | 0.090 |
Why?
|
| Aryldialkylphosphatase | 1 | 2010 | 18 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 853 | 0.080 |
Why?
|
| Catalytic Domain | 1 | 2010 | 193 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2010 | 325 | 0.080 |
Why?
|
| DNA Helicases | 1 | 2011 | 187 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2011 | 298 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 3215 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2009 | 26 | 0.080 |
Why?
|
| Hydrogen Bonding | 1 | 2009 | 125 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 354 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 855 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 326 | 0.080 |
Why?
|
| Axons | 2 | 2023 | 121 | 0.080 |
Why?
|
| Zebrafish | 1 | 2010 | 323 | 0.070 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2007 | 19 | 0.070 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2011 | 424 | 0.070 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 534 | 0.070 |
Why?
|
| Catalysis | 2 | 2007 | 152 | 0.060 |
Why?
|
| Microscopy, Electron | 1 | 2006 | 248 | 0.060 |
Why?
|
| Dopamine | 1 | 2006 | 101 | 0.060 |
Why?
|
| Cerebral Cortex | 2 | 2015 | 251 | 0.050 |
Why?
|
| Biological Assay | 1 | 2022 | 55 | 0.050 |
Why?
|
| Polyphosphates | 1 | 2022 | 12 | 0.050 |
Why?
|
| Stereoisomerism | 1 | 2002 | 67 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2022 | 51 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2014 | 256 | 0.050 |
Why?
|
| Reflex | 1 | 2021 | 28 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2023 | 1142 | 0.050 |
Why?
|
| Virulence | 1 | 2002 | 187 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2002 | 135 | 0.050 |
Why?
|
| Head Injuries, Closed | 1 | 2021 | 14 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2002 | 292 | 0.050 |
Why?
|
| Cations, Monovalent | 1 | 2000 | 1 | 0.040 |
Why?
|
| IMP Dehydrogenase | 1 | 2000 | 2 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2011 | 190 | 0.040 |
Why?
|
| Aged | 2 | 2018 | 13596 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2095 | 0.040 |
Why?
|
| Tunicamycin | 1 | 2018 | 8 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2023 | 1995 | 0.040 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2018 | 17 | 0.040 |
Why?
|
| Transfection | 1 | 2020 | 673 | 0.040 |
Why?
|
| RNA | 2 | 2014 | 404 | 0.040 |
Why?
|
| Proteostasis | 1 | 2018 | 11 | 0.040 |
Why?
|
| Gene Editing | 1 | 2022 | 301 | 0.040 |
Why?
|
| Peptides | 1 | 2002 | 549 | 0.040 |
Why?
|
| Time Factors | 1 | 2006 | 3621 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 496 | 0.040 |
Why?
|
| Tryptophan | 1 | 2018 | 55 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 1965 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 55 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1542 | 0.030 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2015 | 19 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2002 | 818 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1053 | 0.030 |
Why?
|
| Disulfides | 1 | 2014 | 63 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 628 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 75 | 0.030 |
Why?
|
| Artifacts | 1 | 2014 | 126 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 416 | 0.030 |
Why?
|
| Jews | 1 | 2012 | 10 | 0.030 |
Why?
|
| Growth Cones | 1 | 2012 | 14 | 0.030 |
Why?
|
| Aging | 1 | 2018 | 731 | 0.030 |
Why?
|
| Exome | 1 | 2012 | 74 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 184 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 107 | 0.020 |
Why?
|
| Oxygen | 1 | 2013 | 309 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1527 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 852 | 0.020 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2011 | 17 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 262 | 0.020 |
Why?
|
| RNA Helicases | 1 | 2011 | 88 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 617 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2009 | 109 | 0.020 |
Why?
|
| tau Proteins | 1 | 2009 | 103 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2009 | 197 | 0.020 |
Why?
|
| Age of Onset | 1 | 2009 | 168 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2011 | 367 | 0.020 |
Why?
|
| Family | 1 | 2010 | 224 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 5200 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 250 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2009 | 379 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 1301 | 0.020 |
Why?
|
| Exons | 1 | 2009 | 190 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2009 | 161 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 194 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2009 | 254 | 0.020 |
Why?
|
| Synapses | 1 | 2009 | 178 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 396 | 0.020 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2007 | 3 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 2007 | 11 | 0.020 |
Why?
|
| Titrimetry | 1 | 2007 | 11 | 0.020 |
Why?
|
| Aldehydes | 1 | 2006 | 16 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2007 | 135 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 64 | 0.020 |
Why?
|
| Amyloid | 1 | 2006 | 63 | 0.020 |
Why?
|
| Biopolymers | 1 | 2006 | 70 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2006 | 148 | 0.010 |
Why?
|
| Inosine Monophosphate | 1 | 2000 | 1 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2006 | 560 | 0.010 |
Why?
|
| Lithium | 1 | 2000 | 13 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 99 | 0.010 |
Why?
|
| Sodium | 1 | 2000 | 61 | 0.010 |
Why?
|
| Inflammation | 1 | 2006 | 1111 | 0.010 |
Why?
|
| NAD | 1 | 2000 | 48 | 0.010 |
Why?
|
| Magnesium | 1 | 2000 | 58 | 0.010 |
Why?
|
| Potassium | 1 | 2000 | 109 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2009 | 2892 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2000 | 357 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 806 | 0.010 |
Why?
|
| Binding Sites | 1 | 2000 | 893 | 0.010 |
Why?
|